| Sumanna Sankaran, MD | |
|
1500 East Medical Center Drive, 1h247 University Hospital, Ann Arbor, MI 48109-5048 | |
| (734) 936-4280 | |
| (734) 936-9091 |
| Full Name | Sumanna Sankaran |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 19 Years |
| Location | 1500 East Medical Center Drive, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497198717 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 4301102016 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Edward W Sparrow Hospital | Lansing, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Edward W Sparrow Hospital Association | 6709799166 | 522 |
News Archive
Globavir Biosciences, Inc., a biotechnology company developing diagnostic and therapeutic technologies to treat infectious diseases, has announced a partnership with BioManguinhos, a division of the Oswaldo Cruz Foundation, for a joint evaluation of Globavir's PanGlob RT-PCR Dengue diagnostic assay.
Researchers from the Byers Eye Institute at Stanford University have found a way to use artificial intelligence to fight a complication of diabetes that affects the eyes. This advance has the potential to reduce the worldwide rate of vision loss due to diabetes.
University of Alabama at Birmingham researchers have found a marker on blood cells that may help the most pressing problem in chronic myelogenous leukemia, or CML, today — an inability to get patients off treatment.
Today Biogen Idec announced the company recently submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of recombinant factor IX Fc fusion protein (rFIXFc) for the treatment of hemophilia B.
› Verified 5 days ago
| Entity Name | Edward W Sparrow Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366498107 PECOS PAC ID: 6709799166 Enrollment ID: O20040311001138 |
News Archive
Globavir Biosciences, Inc., a biotechnology company developing diagnostic and therapeutic technologies to treat infectious diseases, has announced a partnership with BioManguinhos, a division of the Oswaldo Cruz Foundation, for a joint evaluation of Globavir's PanGlob RT-PCR Dengue diagnostic assay.
Researchers from the Byers Eye Institute at Stanford University have found a way to use artificial intelligence to fight a complication of diabetes that affects the eyes. This advance has the potential to reduce the worldwide rate of vision loss due to diabetes.
University of Alabama at Birmingham researchers have found a marker on blood cells that may help the most pressing problem in chronic myelogenous leukemia, or CML, today — an inability to get patients off treatment.
Today Biogen Idec announced the company recently submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of recombinant factor IX Fc fusion protein (rFIXFc) for the treatment of hemophilia B.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sumanna Sankaran, MD 3621 South State Street, 700 Kms Place, Ann Arbor, MI 48108 Ph: (734) 936-2047 | Sumanna Sankaran, MD 1500 East Medical Center Drive, 1h247 University Hospital, Ann Arbor, MI 48109-5048 Ph: (734) 936-4280 |
News Archive
Globavir Biosciences, Inc., a biotechnology company developing diagnostic and therapeutic technologies to treat infectious diseases, has announced a partnership with BioManguinhos, a division of the Oswaldo Cruz Foundation, for a joint evaluation of Globavir's PanGlob RT-PCR Dengue diagnostic assay.
Researchers from the Byers Eye Institute at Stanford University have found a way to use artificial intelligence to fight a complication of diabetes that affects the eyes. This advance has the potential to reduce the worldwide rate of vision loss due to diabetes.
University of Alabama at Birmingham researchers have found a marker on blood cells that may help the most pressing problem in chronic myelogenous leukemia, or CML, today — an inability to get patients off treatment.
Today Biogen Idec announced the company recently submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of recombinant factor IX Fc fusion protein (rFIXFc) for the treatment of hemophilia B.
› Verified 5 days ago
Paul Derek Fernandes, BM Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1500 East Medical Center Dr, 1h247 University Hospital, Ann Arbor, MI 48109 Phone: 734-936-4280 | |
Thomas F Curran, Anesthesiology Medicare: Medicare Enrolled Practice Location: 2215 Fuller Rd, Ann Arbor, MI 48105 Phone: 734-845-5342 | |
Meghan Horn, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Drive, 1h247 University Hospital, Ann Arbor, MI 48109 Phone: 734-936-4280 | |
Youssef Daklallah, Anesthesiology Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 313-525-1834 | |
Austin Michael Foote, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4280 | |
Andrew James Baldock, BM Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1500 East Medical Center Dr, 1h247 University Hospital, Ann Arbor, MI 48109 Phone: 734-936-4280 | |
Monn Y Lee, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1500 East Medical Center Dr, 1h247 University Hospital, Ann Arbor, MI 48109 Phone: 734-936-4280 |